The stages of dementia, and what to expect at each one

When a doctor first uses the word 'dementia,' the question is: what does this look like over time? Doctors talk about three stages: early (mild), moderate, severe. Inside each there's wide variation; someone with early-stage Alzheimer's may still hold a job, while another at the same stage has stopped driving.

Hallmark: short-term memory trouble. Names slip. Recent conversations don't stick. They may tell you the same story twice in twenty minutes, forget a familiar appointment, get briefly lost on a familiar route. Daily life mostly intact: they cook, dress, manage finances, hold conversations.

What's hard is the awareness. Many in early stage know something is wrong; the fear of losing themselves is its own grief. Reminiscence Therapy is unusually powerful here: early-life memories stay strong while recent memory fades, so the past becomes a source of identity.

Confusion about time becomes routine: they may believe it's a different year or ask about people gone for decades. Multi-step tasks (recipes, paying a bill) become frustrating. Recognition softens: they may know you're 'family' but momentarily lose the name.

This is where 'arguing with the diagnosis' is most painful, and where validation therapy (meeting them in the year they think it is) becomes the clinical gold standard. Don't correct that it's 2026 if mom thinks it's 1998. Walk with her through 1998.

Staging models are orientation, not a roadmap. The CDR and GDS/FAST scales were developed for typical Alzheimer's and fit poorly with frontotemporal, vascular, and Lewy body disease (SAGE review, 2011). Progression within Alzheimer's is nonlinear; hospitalizations, infections, and partial behavioral recovery shift the picture. Survival estimates are unreliable: the 4–8 year post-diagnosis average masks a range from under 2 to over 20 (Mayo Clinic). A daily call catches what an annual visit misses (vocabulary contracting, repetition climbing, time orientation slipping) months or years earlier.

Verbal communication diminishes; some stop speaking in sentences. Most can no longer use a phone independently; calls have to be handed to them by a caregiver. Recognition of even close family fades. The body needs more help: feeding, bathing, mobility.

What's still there is feeling. Music from youth can light up a face that's been still for hours. A familiar voice registers as comfort even when words don't parse. Simulated Presence Therapy was designed for this stage: a recording of a loved one's voice measurably reduces agitation and apathy (Yu et al. 2024).

• Daily emotional connection. Frequency over duration: a short daily call beats a monthly visit.
• Familiar voices. Voices the person already knows are processed differently than strangers, even in late stages.
• Real photos and stories. Anchor conversations in their actual life, not abstract topics. Familiar texts photos live during the call (family photos and Google images surfaced as conversation moves), giving language-challenged stages a visual anchor.
• Routine. Same time, same voice, same shape of conversation reduces anxiety.
• Tracking change. A daily check-in catches transitions weeks or months earlier than a quarterly doctor's visit. Familiar charts the stage-shift markers (vocabulary diversity, repetition rate, name recall, time-orientation, mood) every call and builds a per-receiver baseline after 30 days. When something drifts, you get a flag in the post-call SMS and a clinician-formatted PDF you can hand the doctor at the next visit.

Dr. Rudolph Tanzi (Harvard Medical School; Director of MassGeneral's Genetics and Aging Research Unit) describes on the Nothing Left Unsaid podcast, May 2026 a generation of blood tests that detect Alzheimer's pathology decades before Stage 1 symptoms appear. The most available: pTau217 (Precivity AD2, C2N Diagnostics), ordered by a PCP or neurologist. Results flag whether amyloid is accumulating and whether tau tangles or neuroinflammation are underway, even while cognition still tests normal.

The practical implication: the staging framework above describes what's visible. pTau217 reveals what's already in motion before any stage is visible. Combined with Familiar's daily cognitive-trend data, it gives a doctor the earliest possible picture for deciding when to start SHIELD-protocol lifestyle changes and, where eligible, disease-modifying drugs.